Search results
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoIdeally, these updated vaccines will be available in the fall. The Vaccines and Related Biological...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 1 hour agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 1 day agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days agoThe CDC has recommended that adults 65 and older and people who are immunocompromised get a booster...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 2 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoSo, even if Moderna shares don't take off overnight, the RSV approval is bullish news for shareholders -- and a great reason...provides investors with an...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA advisers urge targeting JN.1 strain for fall’s COVID vaccines
Marshall Independent· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of ...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 1 day agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
